Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26125541 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Paula Alexandra Lopes und 1 weiteren Autor:innen. Beteiligte Einrichtung: CIISA-Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, 1300-477 Lisboa, Portuga…. Hauptthemen laut MEDLINE: Alzheimer Disease, Disease Models, Animal, Translational Research, Biomedical. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 290 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, FCT Stimulus of Scientific Employment Program to P.A.L., FCT Stimulus of the Scientific Employment Program.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer’s disease (AD) is a leading cause of dementia and a growing public health concern worldwide. Despite decades of research, effective disease-modifying treatments remain elusive, partly due to limitations in current experimental models. The purpose of this review is to critically assess and compare existing murine and alternative models of AD to identify key strengths, limitations, and future directions for model development that can enhance translational relevance and therapeutic discovery. Traditional transgenic mouse models have advanced the understanding of amyloid-beta and tau pathologies, but often fail to capture the complexity of sporadic, late-onset AD. In response, alternative models—including zebrafish, Drosophila melanogaster, Caenorhabditis elegans, non-human primates, and human brain organoids—are gaining traction due to their complementary insights and diverse experimental advantages. This review also discusses innovations in genetic engineering, neuroimaging, computational modelling, and drug repurposing that are reshaping the landscape of AD research. By integrating these diverse approaches, the review advocates for a multi-model, multidisciplinary strategy to improve the predictive power, accelerate clinical translation, and inform personalised therapeutic interventions. Ethical considerations and equitable access to diagnostics and emerging treatments are also emphasised. Ultimately, this work aims to support the development of more accurate, effective, and human-relevant models to combat AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CIISA-Centro de Investigação Interdisciplinar em Sanidade Animal, Faculdade de Medicina Veterinária, Universidade de Lisboa, 1300-477 Lisboa, Portugal.
- Laboratório Associado para Ciência Animal e Veterinária (AL4AnimalS), Faculdade de Medicina Veterinária, Universidade de Lisboa, 1300-477 Lisboa, Portugal.
- Departamento de Tecnología de Alimentos, Universidad de Almería, 04120 Almería, Spain.
ORCID-Profile: Paula Alexandra Lopes, José L Guil-Guerrero
Förderung
- Fundação para a Ciência e a Tecnologia
- FCT Stimulus of Scientific Employment Program to P.A.L.
- FCT Stimulus of the Scientific Employment Program
Zitieren
APA
Alexandra Lopes, P., & Guil-Guerrero, J. L. (2025). Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125541
Vancouver
Alexandra Lopes P, Guil-Guerrero JL. Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125541
BibTeX
@article{AlexandraLopes2025,
author = {Alexandra Lopes, Paula and Guil-Guerrero, José L},
title = {Beyond Transgenic Mice: Emerging Models and Translational Strategies in Alzheimer’s Disease},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26125541}
}
EUVIMED